Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ambrogetti D, Berni D, Catarzi S et al. (1996) Ruolo della duttogalattografia nella diagnosi differenziale del carcinoma mammario. [The role of ductal galactography in the differential diagnosis of breast carcinoma]. Radiol Med (Torino) 91:198
Boyd NF, McGuire V, Shannon P et al. (1988) Effect of a low-fat high-carbohydrate diet on Symptoms of cyclical mastopathy. Lancet 2:128
Colin C, Gaspard U, Lambotte R (1978) Relationship of mastodynia with its endocrine environment and treatment in a double blind trial with lynestrenol. Arch Gynakol 225: 7
Dixon JM (1994) ABC of breast diseases. Breast infection. BMJ 309:946
Dixon JM, Mansel RE (1994) ABC of breast diseases. Symptoms assessment and guidelines for referral. BMJ 309: 722
Doberl A, Tobiassen T, Rasmussen T (1984) Treatment of recurrent cyclical mastodynia in patients with fibrocystic breast disease. A double-blind placebo-controlled study — the Hjorring project. Acta Obstet Gynecol Scand [Suppl] 123:177
Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146
Dupont WD, Parl FF, Hartmann WH et al. (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258
Ernster VL, Goodson WH 3rd, Hunt TK et al. (1985) Vitamin E and benign breast « disease“: a double-blind, randomized clinical trial. Surgery 97: 490
Fentiman IS (1986) Tamoxifen and mastalgia. An emerging indication. Drugs 32:477
Fentiman IS (2000) Management of breast pain. In: Harris JR, Lippman ME, Morrow M, Osborne CK (eds) Diseases of the breast, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, p 57
Fentiman IS, Caleffi M, Brame K et al. (1986) Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet 1:287
Fentiman IS, Caleffi M, Hamed H, Chaudary MA (1988) Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg 75: 845
Gadd MA, Souba WW (1998) Evaluation and treatment of benign breast disorders. In: Bland KI, Copeland EM 3rd (eds) The breast: comprehensive management of benign and malignant diseases. WB Saunders, Philadelphia, p 236
GEMB (Grupo de Estudio de Mastopatias Benignas; 1997) Tamoxifen therapy for cyclical mastalgia: dose randomized trial. Breast 5:212
Groves A, Carr M, Wadhera V, Lennard T (1996) An audit of cytology in the evaluation of nipple discharge. A retrospective study of 10 years‘ experience. Breast 5:96
Hinton CP, Bishop HM, Holliday H et al. (1986) A double-blind controlled trial of danazol and bromocriptine in the management of severe cyclical breast pain. Br J Clin Pract 40: 326
Jacobs TW, Byrne C, Colditz G et al. (1999) Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 340:430
Jensen RA, Page DL, Dupont WD, Rogers LW (1989) Invasive breast cancer risk in women with sclerosing adenosis. Cancer 64:1977
Kontostolis E, Stefanidis K, Navrozoglou I, Lolis D (1997) Comparison of tamoxifen with danazol for treatment of cyclical mastalgia. Gynecol Endocrinol 11:393
Kumar S, Mansel RE, Hughes LE et al. (1984) Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer 53:1311
Leinster SJ, Whitehouse GH, Walsh PV (1987) Cyclical mastalgia: clinical and mammographic observations in a screened population. Br J Surg 74: 220
Liberman L, Giess CS, Dershaw DD et al. (1994) Imaging of pregnancy-associated breast cancer. Radiology 191:245
London SJ, Connolly JL, Schnitt SJ, Colditz GA (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941
Maddox PR, Harrison BJ, Horobin JM et al. (1990) A randomised controlled trial of medroxyprogesterone acetate in mastalgia. Ann R Coll Surg Engl 72: 71
Mansel RE, Dogliotti L (1990) European multicentre trial of bromocriptine in cyclical mastalgia. Lancet 335: 190
Mansel RE, Wisbey JR, Hughes LE (1982) Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease. Lancet 1: 928
Marshall LM, Hunter DJ, Connolly JL et al. (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6: 297
McDivitt RW, Stevens JA, Lee NC et al. (1992) Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group. Cancer 69: 1408
McFadyen IJ, Raab GM, Macintyre CC, Forrest AP (1989) Progesterone cream for cyclic breast pain. BMJ 298: 931
Messinis IE, Lolis D (1988) Treatment of premenstrual mastalgia with tamoxifen. Acta Obstet Gynecol Scand 67: 307
Morrow M (2000) Physical examination of the breast. In: Harris JR, Lippman ME, Morrow M, Osborne CK (eds) Diseases of the breast, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, p 33
Morrow M, Wong S, Venta L (1998) The evaluation of breast masses in women younger than forty years of age. Surgery 124: 634–640, discussion 640
Nappi C, Affinito P, Di-Carlo C et al. (1992) Double-blind controlled trial of progesterone vaginal cream treatment for cyclical mastodynia in women with benign breast disease. J Endocrinol Invest 15: 801
Norris TG(2001) Benign breast disease. Radiol Technol 72: 245
Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55: 2698
Page DL, Rogers LW (1992) Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 23: 1095
Palli D, DelTurco MR, Simoncini R, Bianchi S (1991) Benign breast disease and breast cancer: a case-control study in a cohort in Italy. Int J Cancer 71: 703
Peters F (1992) Multicentre study of gestrinone in cyclical breast pain. Lancet 339:205
Powles TJ, Ford HT, Gazet JC (1987) A randomised trial to compare tamoxifen with danazol for treatment of benign mammary dysplasia. Breast Dis 2: 1
Sandrucci S, Mussa A, Festa V et al. (1990) Comparison of tamoxifen and bromocriptine in management of fibrocystic breast disease: a randomized blind study. Ann N Y Acad Sci 586: 626
Schuerch C 3rd, Rosen PP, Hirota T et al. (1982) A pathologic study of benign breast diseases in Tokyo and New York. Cancer 50: 1899
Seltzer MH, Perloff U, Kelley Rl, Fitts WT (1970) The significance of age in patients with nipple discharge. Surg Gynecol Obstet 131:519
Sitruk-Ware LR, Sterkers N, Mowszowicz I, Mauvais-Jarvis P (1977) Inadequate corpus luteal function in women with benign breast diseases. J Clin Endocrinol Metab 44: 771
Skaane P, Engedal K (1998) Analysis of sonographic features in the differentiation of fibroadenoma and invasive ductal carcinoma. Am J Roentgenol 170: 109
Smith DN, Kaelin CM, Korbin CD et al. (1997) Impalpable breast cysts: Utility of Cytologic examination of fluid obtained with radiologically guided aspiration. Radiology 204: 149
Stavros AT, Thickman D, Rapp CL et al. (1995) Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 196: 123
Swinford AE, Adler DD, Garver KA (1998) Mammographic appearance of the breasts during pregnancy and lactation: false assumptions. Acad Radiol 5: 467
Walsh PV, Bulbrook RD, Stell PM et al. (1984) Serum progesterone concentration during the luteal phase in women with benign breast disease. Eur J Cancer Clin Oncol 20: 1339
Walsh PV, McDicken IW, Bulbrook RD et al. (1984) Serum oestradiol-17 beta and prolactin concentrations during the luteal phase in women with benign breast disease. Eur J Cancer Clin Oncol 20: 1345
Watt-Boolsen S, Andersen AN, Blichert-Toft M (1981) Serum prolactin and oestradiol levels in women with cyclical mastalgia. Horm Metab Res 13: 700
Wilkinson S, Anderson TJ, Rifkind E et al. (1989) Fibroadenoma of the breast: a follow-up of conservative management. Br J Surg 76: 390
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Ortmann, O. (2005). Benigne Brusterkrankungen. In: Leidenberger, F., Strowitzki, T., Ortmann, O. (eds) Klinische Endokrinologie für Frauenärzte. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26406-X_21
Download citation
DOI: https://doi.org/10.1007/3-540-26406-X_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-44162-5
Online ISBN: 978-3-540-26406-4
eBook Packages: Medicine (German Language)